Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moyle

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Pain|September 18, 2022
A Comparison of Self-reported Pain Measures Between Sensory Phenotypes in HIV-associated Sensory NeuropathyHarriet I Kemp, Jan Vollert, Nicholas W S Davies, et al.
HIV Clinical Trials|August 30, 2008
Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormoneDerek C Macallan, Christine Baldwin, Sundihya Mandalia, et al.
HIV Clinical Trials|October 9, 2001
Efficacy of a nelfinavir- and nevirapine-containing salvage regimenA K Sullivan, M R Nelson, A Shaw, et al.
Journal of Clinical Pharmacology|September 2, 1998
Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virusG J Moyle, M Youle, C Higgs, et al.
HIV Medicine|March 12, 2004
A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infectionG J Moyle, L Lysakova, S Brown, et al.
Journal of Medical Virology|August 1, 1992
Dideoxyinosine for chronic hepatitis B infectionA P Catterall, G J Moyle, E A Hopes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapyGraeme J Moyle, Eric S Daar, Joseph M Gertner, et al.
Plos One|February 7, 2015
A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individualsGraeme J Moyle, Chloe Orkin, Martin Fisher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination StudyGraeme J Moyle, Edwin DeJesus, Pedro Cahn, et al.
Antiviral Therapy|December 15, 2010
Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive menPaul A Randell, Akil G Jackson, Marta Boffito, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Pain|September 18, 2022
A Comparison of Self-reported Pain Measures Between Sensory Phenotypes in HIV-associated Sensory NeuropathyHarriet I Kemp, Jan Vollert, Nicholas W S Davies, et al.
HIV Clinical Trials|August 30, 2008
Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormoneDerek C Macallan, Christine Baldwin, Sundihya Mandalia, et al.
HIV Clinical Trials|October 9, 2001
Efficacy of a nelfinavir- and nevirapine-containing salvage regimenA K Sullivan, M R Nelson, A Shaw, et al.
Journal of Clinical Pharmacology|September 2, 1998
Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virusG J Moyle, M Youle, C Higgs, et al.
HIV Medicine|March 12, 2004
A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infectionG J Moyle, L Lysakova, S Brown, et al.
Journal of Medical Virology|August 1, 1992
Dideoxyinosine for chronic hepatitis B infectionA P Catterall, G J Moyle, E A Hopes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapyGraeme J Moyle, Eric S Daar, Joseph M Gertner, et al.
Plos One|February 7, 2015
A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individualsGraeme J Moyle, Chloe Orkin, Martin Fisher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination StudyGraeme J Moyle, Edwin DeJesus, Pedro Cahn, et al.
Antiviral Therapy|December 15, 2010
Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive menPaul A Randell, Akil G Jackson, Marta Boffito, et al.
Pageof 8